Synthetic mRNA (mRNA) enables transgene expression without the necessity of nuclear import and the risk of insertional mutagenesis, which makes it an attractive tool for medical applications such as vaccination and protein replacement therapy. For further improvement of mRNA therapeutics, cell-selective translation is desirable, because transgene expression in nontarget cells sometimes causes adverse effects. In this study, we developed an intracellular protein-responsive translational regulation system based on Caliciviral VPg-based translational activator (CaVT) combined with inteins and target protein-binding nanobodies. This system enabled both translational activation and repression in a target protein-dependent manner. Importantly, the target protein can be altered by simply exchanging the nanobodies. The versatile design for target protein-responsive translational regulation holds promise for producing mRNA therapeutics with high safety.

JOURNAL：ACS Synthetic Biology

TITLE：Versatile Design of Intracellular Protein-Responsive Translational Regulation System for Synthetic mRNA

DOI：https://doi.org/10.1021/acssynbio.1c00567

Keiji ITAKA,Ph.D.,Professor

Department of Biofunction Research,
Institute of Biomaterials and Bioengineering,
Tokyo Medical and Dental University(TMDU)
E-mail:itaka.bif(at)tmd.ac.jp

＊Please change (at) in e-mail addresses to @ on sending your e-mail to contact personnels.